Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Febuxostat Add-on Therapy on Albuminuria in Diabetic Kidney Disease Patients Receiving SGLT2 Inhibitors: A Pilot Randomized Controlled Trial
TCTR20260324003Phase 3Not yet recruiting
- Sponsor
- Buriram Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of febuxostat in diabetic glomerulosclerosis, albuminuria, sponsored by Buriram Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
febuxostat
03
Conditions
diabetic glomerulosclerosisalbuminuria
Beyond the preview
Go deeper on TCTR20260324003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260324003.